HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liang-Ming Ma Selected Research

Length of Stay

10/2023[Comparison of Plerixafor or Cyclophosphamide Combined with G-CSF in Mobilization of Peripheral Blood Stem Cells in Multiple Myeloma].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Liang-Ming Ma Research Topics

Disease

5Multiple Myeloma
10/2023 - 08/2020
4Infections
10/2023 - 11/2020
4Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2023 - 11/2020
3Leukemia
01/2023 - 03/2008
2Hemorrhage
01/2023 - 07/2021
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2023 - 08/2019
2Chromosome Aberrations (Chromosome Abnormalities)
01/2023 - 04/2021
2Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2022 - 07/2021
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2013 - 06/2011
2Graft vs Host Disease (Graft-Versus-Host Disease)
08/2012 - 06/2010
1Hematologic Diseases (Blood Diseases)
08/2023
1Cross Infection (Nosocomial Infection)
04/2023
1Thrombosis (Thrombus)
01/2023
1Craniocerebral Trauma (Head Injury)
07/2021
1Pneumonia (Pneumonitis)
11/2020
1Hematologic Neoplasms (Hematological Malignancy)
06/2010

Drug/Important Bio-Agent (IBA)

4Inosine Triphosphate (ITP)IBA
01/2023 - 11/2020
3Bortezomib (Velcade)FDA Link
01/2023 - 06/2011
2CreatinineIBA
08/2023 - 04/2023
2Imatinib Mesylate (Gleevec)FDA Link
08/2013 - 06/2011
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2023
1plerixaforFDA Link
10/2023
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2023
1AlbuminsIBA
08/2023
1ImipenemFDA Link
08/2023
1Carbapenems (Carbapenem Antibiotics)IBA
08/2023
1C-Reactive ProteinIBA
04/2023
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
01/2023
1Lenalidomide (CC 5013)FDA Link
01/2023
1B-Cell Maturation AntigenIBA
06/2021
1Chimeric Antigen ReceptorsIBA
06/2021
1bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
06/2021
1Sorafenib (BAY 43-9006)FDA Link
08/2019
1triptolideIBA
08/2019
1Proteasome InhibitorsIBA
08/2013
1FlagellinIBA
08/2012
1Toll-Like Receptors (Toll-Like Receptor)IBA
08/2012
1Interleukin-2 (IL2)IBA
06/2010
1Transforming Growth Factor beta (TGF-beta)IBA
06/2010
1Arsenic Trioxide (Trisenox)FDA Link
03/2008
1Buthionine SulfoximineIBA
03/2008
1ArsenicIBA
03/2008

Therapy/Procedure

4Hematopoietic Stem Cell Transplantation
01/2023 - 06/2010
2Transplantation
01/2023 - 04/2021
1Length of Stay
10/2023
1Drug Therapy (Chemotherapy)
08/2023
1Therapeutics
08/2020
1Aftercare (After-Treatment)
08/2020